143 related articles for article (PubMed ID: 37981475)
1. Atherosclerotic Cardiovascular Disease Risk and Longitudinal Risk Factor Management Among Patients With Breast Cancer.
Melson JW; Koethe B; Mohanty S; Babroudi S; Bao C; Chunduru A; Dwaah H; Finn M; Jain A; Lalla M; Patnaik P; Studley R; Buchsbaum RJ; Huber K; Parsons SK; Upshaw JN
Clin Breast Cancer; 2024 Feb; 24(2):e71-e79.e4. PubMed ID: 37981475
[TBL] [Abstract][Full Text] [Related]
2. Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA).
Budoff MJ; Young R; Burke G; Jeffrey Carr J; Detrano RC; Folsom AR; Kronmal R; Lima JAC; Liu KJ; McClelland RL; Michos E; Post WS; Shea S; Watson KE; Wong ND
Eur Heart J; 2018 Jul; 39(25):2401-2408. PubMed ID: 29688297
[TBL] [Abstract][Full Text] [Related]
3. Utilization Patterns of Lipid-lowering Therapies in Patients With Atherosclerotic Cardiovascular Disease or Diabetes: A Population-based Study in South Korea.
Kim S; Kim H; Kim E; Han S; Rane PP; Fox KM; Zhao Z; Qian Y; Suh HS
Clin Ther; 2018 Jun; 40(6):940-951.e7. PubMed ID: 29735297
[TBL] [Abstract][Full Text] [Related]
4. Underprescribing of statin therapy in people with HIV at risk for atherosclerotic cardiovascular disease.
Gallegos Aragon K; Ray G; Conklin J; Stever E; Marquez C; Magallanes A; Anderson J; Jakeman B
Am J Health Syst Pharm; 2022 Nov; 79(22):2026-2031. PubMed ID: 35976174
[TBL] [Abstract][Full Text] [Related]
5. Impact of the 2013 Cholesterol Guideline on Patterns of Lipid-Lowering Treatment in Patients with Atherosclerotic Cardiovascular Disease or Diabetes After 1 Year.
Tran JN; Kao TC; Caglar T; Stockl KM; Spertus JA; Lew HC; Solow BK; Chan PS
J Manag Care Spec Pharm; 2016 Aug; 22(8):901-8. PubMed ID: 27459652
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016.
Yao X; Shah ND; Gersh BJ; Lopez-Jimenez F; Noseworthy PA
JAMA Netw Open; 2020 Nov; 3(11):e2025505. PubMed ID: 33216139
[TBL] [Abstract][Full Text] [Related]
7. Vascular Quality of Care Assessment: Clinicians' Adherence to Lipid-Lowering Therapy for Patients with Atherosclerotic Cardiovascular Disease.
Chan J; Rajalingam T; Fossella J; Zhou H; Eisenberg N; Roche-Nagle G
Ann Vasc Surg; 2020 Nov; 69():197-205. PubMed ID: 32554202
[TBL] [Abstract][Full Text] [Related]
8. Five-Year Residual Atherosclerotic Cardiovascular Disease Risk Prediction Model for Statin Treated Patients With Known Cardiovascular Disease.
Wong ND; Zhao Y; Xiang P; Coll B; López JAG
Am J Cardiol; 2020 Dec; 137():7-11. PubMed ID: 32991855
[TBL] [Abstract][Full Text] [Related]
9. Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines.
Steen DL; Khan I; Ansell D; Sanchez RJ; Ray KK
BMJ Open; 2017 Feb; 7(2):e013255. PubMed ID: 28213597
[TBL] [Abstract][Full Text] [Related]
10. Antihyperlipidemic Medication Treatment Patterns and Statin Adherence Among Patients with ASCVD in a Managed Care Plan After Release of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol.
Bellows BK; Olsen CJ; Voelker J; Wander C
J Manag Care Spec Pharm; 2016 Aug; 22(8):892-900. PubMed ID: 27459651
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the European and US guidelines for lipid-lowering therapy in primary prevention of cardiovascular disease.
Delabays B; de La Harpe R; Vollenweider P; Fournier S; Müller O; Strambo D; Graham I; Visseren FLJ; Nanchen D; Marques-Vidal P; Vaucher J
Eur J Prev Cardiol; 2023 Nov; 30(17):1856-1864. PubMed ID: 37290056
[TBL] [Abstract][Full Text] [Related]
12. Contemporary use of lipid-lowering therapy for secondary prevention in Korean patients with atherosclerotic cardiovascular diseases.
Choi SY; Yang BR; Kang HJ; Park KS; Kim HS
Korean J Intern Med; 2020 May; 35(3):593-604. PubMed ID: 31752475
[TBL] [Abstract][Full Text] [Related]
13. Burden of lipoprotein(a) for patients with atherosclerotic cardiovascular disease: A retrospective analysis from the United States.
Fonseca AF; Byrne H; Laguna A; Itani T; Studer R; Heo J; Dillon A; Ferber P; Costa-Scharplatz M
J Manag Care Spec Pharm; 2023 May; 29(5):519-529. PubMed ID: 37121256
[No Abstract] [Full Text] [Related]
14. Long-Term Atherosclerotic Cardiovascular Disease Risk in Patients With Cancer: A Population-Based Study.
Yang L; Zhang N; Yue Q; Song W; Zheng Y; Huang S; Qiu J; Tse G; Li G; Wu S; Liu T
Curr Probl Cardiol; 2023 Jul; 48(7):101693. PubMed ID: 36924906
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular event rates in a high atherosclerotic cardiovascular disease risk population: estimates from Swedish population-based register data.
Lindh M; Banefelt J; Fox KM; Hallberg S; Tai MH; Eriksson M; Villa G; Svensson MK; Qian Y
Eur Heart J Qual Care Clin Outcomes; 2019 Jul; 5(3):225-232. PubMed ID: 30649251
[TBL] [Abstract][Full Text] [Related]
16. Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease.
Rodriguez F; Maron DJ; Knowles JW; Virani SS; Lin S; Heidenreich PA
JAMA Cardiol; 2017 Jan; 2(1):47-54. PubMed ID: 27829091
[TBL] [Abstract][Full Text] [Related]
17. Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases.
Bahiru E; de Cates AN; Farr MR; Jarvis MC; Palla M; Rees K; Ebrahim S; Huffman MD
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD009868. PubMed ID: 28263370
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a novel 10-year cardiovascular risk prediction nomogram for the United Arab Emirates national population.
Al-Shamsi S
BMJ Open; 2022 Dec; 12(12):e064502. PubMed ID: 36581433
[TBL] [Abstract][Full Text] [Related]
19. Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease.
Erqou S; Papaila A; Halladay C; Ge A; Liu MA; Jiang L; Lally M; Menon A; Shah NR; Miech E; Virani SS; Zullo AR; Shireman TI; Longenecker CT; Ross D; Sullivan JL; Wu WC; Rudolph JL
Am Heart J; 2022 Jul; 249():12-22. PubMed ID: 35318028
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics, patterns of lipid-lowering medication use, and health care resource utilization and costs among patients with atherosclerotic cardiovascular disease.
Power TP; Ke X; Zhao Z; Bonine NG; Cziraky MJ; Grabner M; Barron JJ; Quimbo R; Vangerow B; Toth PP
Vasc Health Risk Manag; 2018; 14():23-36. PubMed ID: 29440909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
